FDA nixes Lexicon's diabetes hopeful Zynquista—again
The FDA rejected Lexicon Pharmaceuticals and Sanofi’s Zynquista in March, dashing their hopes of launching the Type 1 diabetes drug this year. | The FDA rejected Lexicon Pharmaceuticals and Sanofi’s...
fiercebiotech.com